,0
symbol,XAIR
price,5.44
beta,-0.225457
volAvg,143181
mktCap,93280768
lastDiv,0.0
range,3.45-12.5
changes,0.12
companyName,Beyond Air Inc
currency,USD
cik,0001641631
isin,US08862L1035
cusip,08862L103
exchange,NasdaqCM
exchangeShortName,NASDAQ
industry,Medical Devices
website,http://www.ait-pharm.com
description,"Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company. The company is headquartered in Garden City, New York and currently employs 18 full-time employees. The firm is focused on developing a nitric oxide (NO) generator and delivery system that generates NO from ambient air. The Beyond Air NOGDS is designed to deliver a dosage of NO to the lungs. The firm focuses on areas, such as persistent pulmonary hypertension of the newborn (PPHN), bronchiolitis (BRO) and nontuberculous mycobacteria (NTM). Its Beyond Air NOGDS also delivers a high concentration of NO to the lungs. The Companyâ€™s products include Beyond Air- PH, Beyond Air- BRO and Beyond Air- NTM."
ceo,Mr. Steven Lisi
sector,Healthcare
country,US
fullTimeEmployees,18
phone,15166658200
address,825 E Gate Blvd Ste 320
city,Garden City
state,NEW YORK
zip,11530
dcfDiff,
dcf,7.75335
image,https://financialmodelingprep.com/image-stock/XAIR.png
ipoDate,2019-05-07
defaultImage,False
